Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients (Supplemental Appendix)

Name: Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients (Supplemental Appendix)
Creator: Daniel Kim
Published: 2023-10-28T07:32:51.870Z
Keywords: Dermatology, Melanoma, Veterans Affairs

Kim, Daniel; Swetter, Susan; Huhmann, Linden; Dizon, Matthew; Ferguson, Jacqueline; Osborne, Thomas; Spence, Allyson; Ziad, Amina; Fillmore, Nathanael; Hartman, Rebecca

doi:10.17632/bd24sh4ngb.1

Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients (Supplemental Appendix)

Published: 28 October 2023| Version 1 | DOI: 10.17632/bd24sh4ngb.1

Contributors:

Daniel Kim, Susan Swetter, Linden Huhmann, Matthew Dizon, Jacqueline Ferguson, Thomas Osborne, Allyson Spence, Amina Ziad, Nathanael Fillmore, Rebecca Hartman

Description

Supplemental methods and tables for the manuscript entitled "Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients."

Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among Veteran cutaneous melanoma patients (Supplemental Appendix)

Description

Files

Categories

Licence